The gut barrier also features ATP-binding cassette transporters that prevent toxin accumulation and inflammation, influenced by gut microbiota (172, 173)
Anderson, MD, MAS, an assistant professor of medicine at the University of Pittsburgh, and Deborah Grady, MD, MPH, a professor emeritus of medicine and of epidemiology and biostatistics at the University of California, San Francisco, reiterated that the findings are reassuring and support preliminary data from the FDA and European Medicines Agency, but the results do not answer definitely whether or not this drug class poses safety concerns regarding mental health
Clinical evidence The STEP 1 trial showed participants achieved an average 14.9% weight loss over 68 weeks with semaglutide 2.4 mg
Your weight loss journey with us includes InBody scanning